| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Arnold J Levine is Director at PMVP. Arnold J Levine's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $566K at current prices.
Our model assigns Arnold J Levine a strong insider score of 79/100, based on 5 past trades. Over a 12-month horizon, all 5 of those trades were profitable, with an average 12-month return of +59.3%.
The PMVP filings lean toward selling, a net 17,500 shares.
Arnold J Levine has 15 Form 4 filings on record from June 2019 to June 2026, across 2 companies: Director at PMV Pharmaceuticals (PMVP), 2021–2026; Director at MeiraGTx (MGTX), 2019–2022.
The 20 reported transactions were 13 option or other derivative awards and 7 open-market sales.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $568K.
The largest open-market sale was 3,500 shares of PMVP at an average $35.12 on July 20, 2021, about $123K. Twelve months later PMVP was down 57%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 3,500 | $30.00 | $105,000.00 | -0.8% | -18.1% | -58.8% | |
| Aug 23, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 3,500 | $29.50 | $103,250.00 | -0.8% | -20.2% | -53.0% | |
| Jul 20, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 3,500 | $35.12 | $122,929.10 | -0.8% | -33.0% | -57.2% | |
| Jun 21, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 3,500 | $33.25 | $116,362.34 | -0.8% | -17.8% | -67.2% | |
| May 20, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 3,500 | $34.51 | $120,767.93 | -0.8% | -9.0% | -60.1% |